Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-11

FDA Approved: ALENDRONATE SODIUM — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' Original Application (ANDA) for alendronate sodium (ALENDRONATE SODIUM).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

ORIG AP for ALENDRONATE SODIUM (ALENDRONATE SODIUM)